• Profile
Close

Use of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of polymyalgia rheumatica - A prospective study of 99 patients

Rheumatology Oct 25, 2017

Henckaerts L, et al. - A prospective study of 99 patients is carried out to investigate the utilization of 18F-fluorodeoxyglucose (FDG) positron emission tomography in the diagnosis of polymyalgia rheumatica. The outcome of this study suggests that the 18F-FDG-PET before starting glucocorticoid therapy improves the diagnostic accuracy compared with a clinical scoring system in patients with clinical suspicion of polymyalgia rheumatica (PMR).
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay